Dr. Ratner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave
Yale Physicians Bldg 3RD FLR
New Haven, CT 06519Phone+1 203-785-4176Fax+1 203-785-5886
Summary
- Dr. Elena Ratner is an obstetrician/gynecologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital and Lawrence + Memorial Hospital. She received her medical degree from University at Buffalo, School of Medicine and Biomedical Sciences and has been in practice 14 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology and gynecologic oncology.
Education & Training
- Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2007 - 2010
- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 2003 - 2007
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
- CT State Medical License 2007 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- 34 citationsTriapine Disrupts CtIP-Mediated Homologous Recombination Repair and Sensitizes Ovarian Cancer Cells to PARP and Topoisomerase InhibitorsZ. Ping Lin, Elena Ratner, Margaret Whicker, Yashang Lee, Alan C. Sartorelli
Molecular Cancer Research. 2014-03-01 - 349 citationsOvarian cancer, version 2.2020Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht
Journal of the National Comprehensive Cancer Network. 2021-02-02 - 97 citationsPhase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)Alessandro D. Santin, Wei Deng, Michael Frumovitz, Natalia Buza, Stefania Bellone
Gynecologic Oncology. 2020-04-01
Journal Articles
- Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
Press Mentions
- 2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023
- Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
- When Cancer Upends Your Sex LifeMarch 10th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: